618 related articles for article (PubMed ID: 18513192)
21. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging.
Brown G; Radcliffe AG; Newcombe RG; Dallimore NS; Bourne MW; Williams GT
Br J Surg; 2003 Mar; 90(3):355-64. PubMed ID: 12594673
[TBL] [Abstract][Full Text] [Related]
22. MRI after chemoradiotherapy of rectal cancer: a useful tool to select patients for local excision.
Engelen SM; Beets-Tan RG; Lahaye MJ; Lammering G; Jansen RL; van Dam RM; Konsten J; Leijtens JW; van de Velde CJ; Beets GL
Dis Colon Rectum; 2010 Jul; 53(7):979-86. PubMed ID: 20551748
[TBL] [Abstract][Full Text] [Related]
23. Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point.
Guillem JG; Chessin DB; Shia J; Moore HG; Mazumdar M; Bernard B; Paty PB; Saltz L; Minsky BD; Weiser MR; Temple LK; Cohen AM; Wong WD
J Clin Oncol; 2005 May; 23(15):3475-9. PubMed ID: 15908656
[TBL] [Abstract][Full Text] [Related]
24. The accurate staging of ovarian cancer using 3T magnetic resonance imaging--a realistic option.
Booth SJ; Turnbull LW; Poole DR; Richmond I
BJOG; 2008 Jun; 115(7):894-901. PubMed ID: 18485169
[TBL] [Abstract][Full Text] [Related]
25. Accuracy of MRI for predicting the circumferential resection margin, mesorectal fascia invasion, and tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
Kim SH; Lee JM; Park HS; Eun HW; Han JK; Choi BI
J Magn Reson Imaging; 2009 May; 29(5):1093-101. PubMed ID: 19388124
[TBL] [Abstract][Full Text] [Related]
26. [Efficacy comparison of neoadjuvant radiotherapy with or without chemotherapy for locally advanced rectal cancer].
Wu B; Qiu HZ; Xiao Y; Lin GL; Niu BZ; Zhang FQ; Hu K
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Mar; 11(2):124-7. PubMed ID: 18344077
[TBL] [Abstract][Full Text] [Related]
27. Accuracy of gadofosveset-enhanced MRI for nodal staging and restaging in rectal cancer.
Lambregts DM; Beets GL; Maas M; Kessels AG; Bakers FC; Cappendijk VC; Engelen SM; Lahaye MJ; de Bruïne AP; Lammering G; Leiner T; Verwoerd JL; Wildberger JE; Beets-Tan RG
Ann Surg; 2011 Mar; 253(3):539-45. PubMed ID: 21239980
[TBL] [Abstract][Full Text] [Related]
28. [Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].
Mátrai Z; Lövey J; Hitre E; Orosz Z; Gödény M; Péley G; Sulyok Z; Rényi Vámos F; Farkas E; Köves I
Orv Hetil; 2006 Oct; 147(42):2011-20. PubMed ID: 17165600
[TBL] [Abstract][Full Text] [Related]
29. Preoperative staging of rectal carcinoma by magnetic resonance imaging with a pelvic phased-array coil.
Hadfield MB; Nicholson AA; MacDonald AW; Farouk R; Lee PW; Duthie GS; Monson JR
Br J Surg; 1997 Apr; 84(4):529-31. PubMed ID: 9112909
[TBL] [Abstract][Full Text] [Related]
30. Comparison between 3-T magnetic resonance imaging and multi-detector row computed tomography for the preoperative evaluation of rectal cancer.
Kim CK; Kim SH; Choi D; Kim MJ; Chun HK; Lee SJ; Lee JM
J Comput Assist Tomogr; 2007; 31(6):853-9. PubMed ID: 18043346
[TBL] [Abstract][Full Text] [Related]
31. Pre-operative assessment of extramural invasion and sphincteral involvement in rectal cancer by magnetic resonance imaging with phased-array coil.
Ferri M; Laghi A; Mingazzini P; Iafrate F; Meli L; Ricci F; Passariello R; Ziparo V
Colorectal Dis; 2005 Jul; 7(4):387-93. PubMed ID: 15932564
[TBL] [Abstract][Full Text] [Related]
32. Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer.
Suárez J; Vera R; Balén E; Gómez M; Arias F; Lera JM; Herrera J; Zazpe C
Colorectal Dis; 2008 Jul; 10(6):563-8. PubMed ID: 18070184
[TBL] [Abstract][Full Text] [Related]
33. Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer.
Ceelen W; Boterberg T; Pattyn P; van Eijkeren M; Gillardin JM; Demetter P; Smeets P; Van Damme N; Monsaert E; Peeters M
Ann Surg Oncol; 2007 Feb; 14(2):424-31. PubMed ID: 17096057
[TBL] [Abstract][Full Text] [Related]
34. Evaluating mesorectal lymph nodes in rectal cancer before and after neoadjuvant chemoradiation using thin-section T2-weighted magnetic resonance imaging.
Koh DM; Chau I; Tait D; Wotherspoon A; Cunningham D; Brown G
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):456-61. PubMed ID: 18164860
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the sensitivity, specificity, positive and negative predictive values of preoperative magnetic resonance imaging for staging endometrial cancer. A prospective study of 100 cases at the Dorset Cancer Centre.
Ortashi O; Jain S; Emannuel O; Henry R; Wood A; Evans J
Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):232-5. PubMed ID: 17537566
[TBL] [Abstract][Full Text] [Related]
36. [Evaluation of the preoperative staging of rectal cancer by magnetic resonance imaging].
Xu JM; Zhong YS; Zeng MS; Rao SX; Niu WX; Wei Y; Ren L; Qin XY
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Mar; 11(2):132-5. PubMed ID: 18344079
[TBL] [Abstract][Full Text] [Related]
37. Cyclooxygenase-2 expression in pretreatment biopsy as a predictor of tumor responses after preoperative chemoradiation in rectal cancer.
Min BS; Choi YJ; Pyo HR; Kim H; Seong J; Chung HC; Rha SY; Kim NK
Arch Surg; 2008 Nov; 143(11):1091-7; discussion 1097. PubMed ID: 19015468
[TBL] [Abstract][Full Text] [Related]
38. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
[TBL] [Abstract][Full Text] [Related]
39. Role of biopsies in patients with residual rectal cancer following neoadjuvant chemoradiation after downsizing: can they rule out persisting cancer?
Perez RO; Habr-Gama A; Pereira GV; Lynn PB; Alves PA; Proscurshim I; Rawet V; Gama-Rodrigues J
Colorectal Dis; 2012 Jun; 14(6):714-20. PubMed ID: 22568644
[TBL] [Abstract][Full Text] [Related]
40. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
